Medite Cancer Diagnostics, Inc. (MDIT)
OTCMKTS
· Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Aug 12, 2025
Medite Cancer Diagnostics Market Cap
Medite Cancer Diagnostics has a market cap or net worth of $86.00 as of August 15, 2025. Its market cap has decreased by -100.00% in one year.
Market Cap
86.00
Enterprise Value
n/a
Revenue
8.13M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since December 7, 1998, Medite Cancer Diagnostics's market cap has decreased from 591.70K to 86.00, a decrease of -99.99%. That is a compound annual growth rate of -28.18%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 781.22M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 580.89M |
| Glass House Brands | 567.91M |
| American Oncology Network | 379.23M |
| Northwest Biotherapeutics | 363.17M |
| CytoDyn | 344.75M |